NCT03994549View on ClinicalTrials.gov

A Single Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 14, 2019

Primary Completion Date

November 2, 2020

Study Completion Date

November 2, 2020

Conditions
Healthy
Interventions
DRUG

Dual GLP-1/GLP-2 Receptor agonists

Eight ascending doses of ZP7570

Trial Locations (1)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

Sponsors

Lead Sponsor

Zealand Pharma
All Listed Sponsors
lead

Zealand Pharma

INDUSTRY